Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review

INTRODUCTION: Valproic acid (VPA) is widely used for the treatment of epilepsy, migraine, and a variety of psychiatric conditions. The reported incidences of hyperammonemia induced by VPA use is variable. The purpose of this study is to evaluate the incidence of VPA-induced hyperammonemia in the gen...

Descripción completa

Detalles Bibliográficos
Autores principales: McMorris, Tressa, Chu, Angela, Vu, Lynn, Bernardini, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287865/
https://www.ncbi.nlm.nih.gov/pubmed/34316420
http://dx.doi.org/10.9740/mhc.2021.07.243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287865/
https://www.ncbi.nlm.nih.gov/pubmed/34316420
http://dx.doi.org/10.9740/mhc.2021.07.243

Ejemplares similares